MIYABE C[au] - Search Results

Year	Number of Results
2011	3
2012	3
2013	5
2014	5
2015	1
2016	4
2017	5
2018	2
2019	6
2020	5
2021	8
2022	3

1

Editorial: Targeting the Chemoattractant System in Inflammation.

Hosoya T, Cordelia D, Michael BD, Miyabe C, Nagai J, Murooka TT, Miyabe Y. Hosoya T, et al. Among authors: miyabe c. Front Pharmacol. 2021 Aug 16;12:744290. doi: 10.3389/fphar.2021.744290. eCollection 2021. Front Pharmacol. 2021. PMID: 34483948 Free PMC article. No abstract available.

2

Pathogens in Vasculitis: Is It Really Idiopathic?

Miyabe C, Miyabe Y, Miyata R, Ishiguro N. Miyabe C, et al. JMA J. 2021 Jul 15;4(3):216-224. doi: 10.31662/jmaj.2021-0021. Epub 2021 Jul 9. JMA J. 2021. PMID: 34414315 Free PMC article. Review.

3

Hypergammaglobulinemic purpura: Does hypergammaglobulinemia cause purpura?

Kimura K, Miyabe C, Miyata R, Fukuya Y, Ishiguro N. Kimura K, et al. Among authors: miyabe c. J Dermatol. 2021 Nov;48(11):e556-e557. doi: 10.1111/1346-8138.16122. Epub 2021 Aug 24. J Dermatol. 2021. PMID: 34427357 No abstract available.

4

LTB₄ and BLT1 in inflammatory arthritis.

Miyabe Y, Miyabe C, Luster AD. Miyabe Y, et al. Among authors: miyabe c. Semin Immunol. 2017 Oct;33:52-57. doi: 10.1016/j.smim.2017.09.009. Semin Immunol. 2017. PMID: 29042029 Review.

5

Case of hypergammaglobulinemic purpura successfully treated with colchicine.

Kimura K, Miyabe C, Nakamura S, Tochihara M, Ishiguro N. Kimura K, et al. Among authors: miyabe c. J Dermatol. 2021 Oct;48(10):E524-E525. doi: 10.1111/1346-8138.16078. Epub 2021 Jul 19. J Dermatol. 2021. PMID: 34288087 No abstract available.

6

Targeting the Chemokine System in Rheumatoid Arthritis and Vasculitis.

Miyabe Y, Miyabe C, Iwai Y, Luster AD. Miyabe Y, et al. Among authors: miyabe c. JMA J. 2020 Jul 15;3(3):182-192. doi: 10.31662/jmaj.2020-0019. Epub 2020 Jul 13. JMA J. 2020. PMID: 33150252 Free PMC article. Review.

7

Chemokines in rheumatic diseases: pathogenic role and therapeutic implications.

Miyabe Y, Lian J, Miyabe C, Luster AD. Miyabe Y, et al. Among authors: miyabe c. Nat Rev Rheumatol. 2019 Dec;15(12):731-746. doi: 10.1038/s41584-019-0323-6. Epub 2019 Nov 8. Nat Rev Rheumatol. 2019. PMID: 31705045 Review.

8

Design and Synthesis of Highly Potent and Specific ABHD6 Inhibitors.

Malamas MS, Lamani M, Farah SI, Mohammad KA, Miyabe CY, Rajarshi G, Wu S, Zvonok N, Chandrashekhar H, Wood J, Makriyannis A. Malamas MS, et al. Among authors: miyabe cy. ChemMedChem. 2021 Sep 6:10.1002/cmdc.202100406. doi: 10.1002/cmdc.202100406. Online ahead of print. ChemMedChem. 2021. PMID: 34486233

9

Could retinoids be a potential treatment for rheumatic diseases?

Miyabe Y, Miyabe C, Nanki T. Miyabe Y, et al. Among authors: miyabe c. Rheumatol Int. 2015 Jan;35(1):35-41. doi: 10.1007/s00296-014-3067-2. Epub 2014 Jun 18. Rheumatol Int. 2015. PMID: 24939557 Review.

10

Dectin-2-induced CCL2 production in tissue-resident macrophages ignites cardiac arteritis.

Miyabe C, Miyabe Y, Bricio-Moreno L, Lian J, Rahimi RA, Miura NN, Ohno N, Iwakura Y, Kawakami T, Luster AD. Miyabe C, et al. J Clin Invest. 2019 Jun 6;129(9):3610-3624. doi: 10.1172/JCI123778. J Clin Invest. 2019. PMID: 31169521 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results